Friedman School of Nutrition Science and Policy, Tufts University, Boston, MA (K.H., M.D., Z.L., D.M., P.S., S.B.C., S.C.F., F.F.Z.).
Chan Medical School, University of Massachusetts, Worcester, MA (K.H.).
Circ Cardiovasc Qual Outcomes. 2023 Sep;16(9):e009520. doi: 10.1161/CIRCOUTCOMES.122.009520. Epub 2023 Aug 29.
Produce prescriptions may improve cardiometabolic health by increasing fruit and vegetable (F&V) consumption and food insecurity yet impacts on clinical outcomes and health status have not been evaluated in large, multisite evaluations.
This multisite, pre- and post-evaluation used individual-level data from 22 produce prescription locations in 12 US states from 2014 to 2020. No programs were previously evaluated. The study included 3881 individuals (2064 adults aged 18+ years and 1817 children aged 2-17 years) with, or at risk for, poor cardiometabolic health recruited from clinics serving low-income neighborhoods. Programs provided financial incentives to purchase F&V at grocery stores or farmers markets (median, $63/months; duration, 4-10 months). Surveys assessed F&V intake, food security, and self-reported health; glycated hemoglobin, blood pressure, body mass index (BMI), and BMI -score were measured at clinics. Adjusted, multilevel mixed models accounted for clustering by program.
After a median participation of 6.0 months, F&V intake increased by 0.85 (95% CI, 0.68-1.02) and 0.26 (95% CI, 0.06-0.45) cups per day among adults and children, respectively. The odds of being food insecure dropped by one-third (odds ratio, 0.63 [0.52-0.76]) and odds of improving 1 level in self-reported health status increased for adults (odds ratio, 1.62 [1.30-2.02]) and children (odds ratio, 2.37 [1.70-3.31]). Among adults with glycated hemoglobin ≥6.5%, glycated hemoglobin declined by -0.29% age points (-0.42 to -0.16); among adults with hypertension, systolic and diastolic blood pressures declined by -8.38 mm Hg (-10.13 to -6.62) and -4.94 mm Hg (-5.96 to -3.92); and among adults with overweight or obesity, BMI decreased by -0.36 kg/m (-0.64 to -0.09). Child BMI -score did not change -0.01 (-0.06 to 0.04).
In this large, multisite evaluation, produce prescriptions were associated with significant improvements in F&V intake, food security, and health status for adults and children, and clinically relevant improvements in glycated hemoglobin, blood pressure, and BMI for adults with poor cardiometabolic health.
通过增加水果和蔬菜(F&V)的消费以及减少食物不安全感,生产处方可能会改善心脏代谢健康,但在大型多地点评估中尚未评估其对临床结果和健康状况的影响。
本项多地点、前后评估使用了来自美国 12 个州的 22 个生产处方地点的 2014 年至 2020 年的个人水平数据。此前没有对任何方案进行评估。该研究包括 3881 名(2064 名成年人年龄在 18 岁及以上,1817 名儿童年龄在 2-17 岁)患有或有罹患心脏代谢不良风险的人群,他们从服务于低收入社区的诊所招募。这些方案为在杂货店或农贸市场购买 F&V 提供了经济激励(中位数为 63 美元/月;持续时间为 4-10 个月)。调查评估了 F&V 的摄入量、食物保障和自我报告的健康状况;在诊所测量糖化血红蛋白、血压、体重指数(BMI)和 BMI 得分。调整后的多层次混合模型考虑了按方案进行的聚类。
在平均参与时间为 6.0 个月后,成年人和儿童的 F&V 摄入量分别增加了 0.85(95%置信区间,0.68-1.02)和 0.26(95%置信区间,0.06-0.45)杯/天。食物不安全的可能性降低了三分之一(优势比,0.63[0.52-0.76]),成年人(优势比,1.62[1.30-2.02])和儿童(优势比,2.37[1.70-3.31])自我报告的健康状况改善了一个等级。对于糖化血红蛋白≥6.5%的成年人,糖化血红蛋白下降了 0.29%年龄点(-0.42 至-0.16);对于高血压成年人,收缩压和舒张压分别下降了 8.38mmHg(-10.13 至-6.62)和 4.94mmHg(-5.96 至-3.92);对于超重或肥胖的成年人,BMI 下降了 0.36kg/m(-0.64 至-0.09)。儿童 BMI 得分没有变化(-0.01[-0.06 至 0.04])。
在这项大型多地点评估中,生产处方与成年人和儿童的 F&V 摄入量、食物保障和健康状况的显著改善相关,对于患有心脏代谢不良的成年人,糖化血红蛋白、血压和 BMI 也有临床相关的改善。